Effects of immunosuppressive therapy in biopsy-proved myocarditis and borderline myocarditis on left ventricular function

Steven Jones, Ahvie Herskowitz, Grover M. Hutchins, Kenneth L. Baughman

Research output: Contribution to journalArticle

Abstract

Twenty patients with decreased left ventricular (LV) function and endomyocardial biopsy-proved myocarditis (9 patients) or borderline myocarditis (11 patients) were studied to determine whether these 2 histologic subsets of patients with inflammatory heart disease differed in their response to a 6- to 8-week course of immunosuppressive therapy. All patients received a regimen of prednisone, 1.0 mg/kg/day, and azathioprine, 1.5 mg/kg/day, followed by repeat endomyocardial biopsy and reevaluation of LV function. LV function improved significantly in the group with borderline myocarditis, as assessed by LV stroke work-end-diastolic volume ratio (0.26 ± 0.17 to 0.54 ± 0.31 kg · m · ml-1, p <0.02), heart rate corrected velocity of circumferential shortening (0.49 ± 0.30 to 0.80 ± 0.29 circ · s-1, p <0.05), and LV ejection fraction (0.30 ± 0.15 to 0.47 ± 0.13, p <0.05). LV enddiastolic and end-systolic volume indexes also decreased significantly from 129 ± 40 to 94 ± 38 (p <0.05) and 90 ± 37 to 49 ± 26 ml (p <0.02), respectively. No significant change in these indexes of LV function or volume occurred in the myocarditis group. Whereas salutory improvements in cardiac output and filling pressures were found in both groups, objective improvement in LV function assessed by complementary indexes of contractility was greatest in the borderline myocarditis group. It is concluded that short-term immunosuppressive therapy improves LV contractile function and appears to be associated with regression of ventricular dilatation in patients with borderline myocarditis to a greater extent than patients with myocarditis. These data suggest that the patients with borderline myocarditis may benefit from immunosuppressive therapy and should be considered for inclusion in subsequent trials of immunosuppressive therapy in myocarditis.

Original languageEnglish (US)
Pages (from-to)370-376
Number of pages7
JournalThe American Journal of Cardiology
Volume68
Issue number4
DOIs
StatePublished - Aug 1 1991

Fingerprint

Myocarditis
Immunosuppressive Agents
Left Ventricular Function
Biopsy
Therapeutics
Stroke Volume
Azathioprine
Prednisone
Cardiac Output
Dilatation
Heart Diseases
Heart Rate
Stroke
Pressure

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Effects of immunosuppressive therapy in biopsy-proved myocarditis and borderline myocarditis on left ventricular function. / Jones, Steven; Herskowitz, Ahvie; Hutchins, Grover M.; Baughman, Kenneth L.

In: The American Journal of Cardiology, Vol. 68, No. 4, 01.08.1991, p. 370-376.

Research output: Contribution to journalArticle

@article{e79bdf0db1bc4cc4bd2d72f76cb6617b,
title = "Effects of immunosuppressive therapy in biopsy-proved myocarditis and borderline myocarditis on left ventricular function",
abstract = "Twenty patients with decreased left ventricular (LV) function and endomyocardial biopsy-proved myocarditis (9 patients) or borderline myocarditis (11 patients) were studied to determine whether these 2 histologic subsets of patients with inflammatory heart disease differed in their response to a 6- to 8-week course of immunosuppressive therapy. All patients received a regimen of prednisone, 1.0 mg/kg/day, and azathioprine, 1.5 mg/kg/day, followed by repeat endomyocardial biopsy and reevaluation of LV function. LV function improved significantly in the group with borderline myocarditis, as assessed by LV stroke work-end-diastolic volume ratio (0.26 ± 0.17 to 0.54 ± 0.31 kg · m · ml-1, p <0.02), heart rate corrected velocity of circumferential shortening (0.49 ± 0.30 to 0.80 ± 0.29 circ · s-1, p <0.05), and LV ejection fraction (0.30 ± 0.15 to 0.47 ± 0.13, p <0.05). LV enddiastolic and end-systolic volume indexes also decreased significantly from 129 ± 40 to 94 ± 38 (p <0.05) and 90 ± 37 to 49 ± 26 ml (p <0.02), respectively. No significant change in these indexes of LV function or volume occurred in the myocarditis group. Whereas salutory improvements in cardiac output and filling pressures were found in both groups, objective improvement in LV function assessed by complementary indexes of contractility was greatest in the borderline myocarditis group. It is concluded that short-term immunosuppressive therapy improves LV contractile function and appears to be associated with regression of ventricular dilatation in patients with borderline myocarditis to a greater extent than patients with myocarditis. These data suggest that the patients with borderline myocarditis may benefit from immunosuppressive therapy and should be considered for inclusion in subsequent trials of immunosuppressive therapy in myocarditis.",
author = "Steven Jones and Ahvie Herskowitz and Hutchins, {Grover M.} and Baughman, {Kenneth L.}",
year = "1991",
month = "8",
day = "1",
doi = "10.1016/0002-9149(91)90834-8",
language = "English (US)",
volume = "68",
pages = "370--376",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Effects of immunosuppressive therapy in biopsy-proved myocarditis and borderline myocarditis on left ventricular function

AU - Jones, Steven

AU - Herskowitz, Ahvie

AU - Hutchins, Grover M.

AU - Baughman, Kenneth L.

PY - 1991/8/1

Y1 - 1991/8/1

N2 - Twenty patients with decreased left ventricular (LV) function and endomyocardial biopsy-proved myocarditis (9 patients) or borderline myocarditis (11 patients) were studied to determine whether these 2 histologic subsets of patients with inflammatory heart disease differed in their response to a 6- to 8-week course of immunosuppressive therapy. All patients received a regimen of prednisone, 1.0 mg/kg/day, and azathioprine, 1.5 mg/kg/day, followed by repeat endomyocardial biopsy and reevaluation of LV function. LV function improved significantly in the group with borderline myocarditis, as assessed by LV stroke work-end-diastolic volume ratio (0.26 ± 0.17 to 0.54 ± 0.31 kg · m · ml-1, p <0.02), heart rate corrected velocity of circumferential shortening (0.49 ± 0.30 to 0.80 ± 0.29 circ · s-1, p <0.05), and LV ejection fraction (0.30 ± 0.15 to 0.47 ± 0.13, p <0.05). LV enddiastolic and end-systolic volume indexes also decreased significantly from 129 ± 40 to 94 ± 38 (p <0.05) and 90 ± 37 to 49 ± 26 ml (p <0.02), respectively. No significant change in these indexes of LV function or volume occurred in the myocarditis group. Whereas salutory improvements in cardiac output and filling pressures were found in both groups, objective improvement in LV function assessed by complementary indexes of contractility was greatest in the borderline myocarditis group. It is concluded that short-term immunosuppressive therapy improves LV contractile function and appears to be associated with regression of ventricular dilatation in patients with borderline myocarditis to a greater extent than patients with myocarditis. These data suggest that the patients with borderline myocarditis may benefit from immunosuppressive therapy and should be considered for inclusion in subsequent trials of immunosuppressive therapy in myocarditis.

AB - Twenty patients with decreased left ventricular (LV) function and endomyocardial biopsy-proved myocarditis (9 patients) or borderline myocarditis (11 patients) were studied to determine whether these 2 histologic subsets of patients with inflammatory heart disease differed in their response to a 6- to 8-week course of immunosuppressive therapy. All patients received a regimen of prednisone, 1.0 mg/kg/day, and azathioprine, 1.5 mg/kg/day, followed by repeat endomyocardial biopsy and reevaluation of LV function. LV function improved significantly in the group with borderline myocarditis, as assessed by LV stroke work-end-diastolic volume ratio (0.26 ± 0.17 to 0.54 ± 0.31 kg · m · ml-1, p <0.02), heart rate corrected velocity of circumferential shortening (0.49 ± 0.30 to 0.80 ± 0.29 circ · s-1, p <0.05), and LV ejection fraction (0.30 ± 0.15 to 0.47 ± 0.13, p <0.05). LV enddiastolic and end-systolic volume indexes also decreased significantly from 129 ± 40 to 94 ± 38 (p <0.05) and 90 ± 37 to 49 ± 26 ml (p <0.02), respectively. No significant change in these indexes of LV function or volume occurred in the myocarditis group. Whereas salutory improvements in cardiac output and filling pressures were found in both groups, objective improvement in LV function assessed by complementary indexes of contractility was greatest in the borderline myocarditis group. It is concluded that short-term immunosuppressive therapy improves LV contractile function and appears to be associated with regression of ventricular dilatation in patients with borderline myocarditis to a greater extent than patients with myocarditis. These data suggest that the patients with borderline myocarditis may benefit from immunosuppressive therapy and should be considered for inclusion in subsequent trials of immunosuppressive therapy in myocarditis.

UR - http://www.scopus.com/inward/record.url?scp=0025813498&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025813498&partnerID=8YFLogxK

U2 - 10.1016/0002-9149(91)90834-8

DO - 10.1016/0002-9149(91)90834-8

M3 - Article

C2 - 1858678

AN - SCOPUS:0025813498

VL - 68

SP - 370

EP - 376

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 4

ER -